Rocket


News + Filings
Transactions





Mehra Anand

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
06/08/2023Merus N.V.MRUSGrantShare option (right to buy)14.4k$23.29$335.7k 06/08/2023
06/02/2023Aclaris Therapeutics, Inc.ACRSExerciseRestricted Stock Units4.5k$0.00$0 06/01/2023
06/01/2023Aclaris Therapeutics, Inc.ACRSGrantStock Option (Right to Buy)15.8k$8.70$137k 06/01/2023
06/01/2023Aclaris Therapeutics, Inc.ACRSGrantRestricted Stock Units4.7k$0.00$0 06/01/2023
06/03/2022Aclaris Therapeutics, Inc.ACRSExerciseRestricted Stock Units3.4k$0.00$0 06/02/2022
06/02/2022Aclaris Therapeutics, Inc.ACRSGrantStock Option (Right to Buy)15.8k$14.48$228.1k 06/02/2022
06/02/2022Aclaris Therapeutics, Inc.ACRSGrantRestricted Stock Units4.5k$0.00$0 06/02/2022
05/31/2022Merus N.V.MRUSGrantShare option (right to buy)16.6k$18.56$308.2k 05/31/2022
06/03/2021Aclaris Therapeutics, Inc.ACRSGrantStock Option (Right to Buy)12.2k$21.90$268.3k 06/03/2021
06/03/2021Aclaris Therapeutics, Inc.ACRSGrantRestricted Stock Units3.4k$0.00$0 06/03/2021
05/28/2021Merus N.V.MRUSGrantShare option (right to buy)6.1k$21.15$129.4k 05/28/2021
02/02/2021Aclaris Therapeutics, Inc.ACRSExerciseOption Grant (right to buy)8k$18.35$146.8k 02/02/2021
02/02/2021Aclaris Therapeutics, Inc.ACRSExerciseOption Grant (right to buy)6.6k$18.32$121.5k 02/02/2021
06/30/2020Merus N.V.MRUSGrantShare Option (right to buy)8.6k$16.09$138.9k 06/30/2020
06/06/2020Aclaris Therapeutics, Inc.ACRSExerciseRestricted Stock Units7.3k$0.00$0 06/04/2020
06/04/2020Aclaris Therapeutics, Inc.ACRSGrantOption Grant (right to buy)16.5k$1.41$23.3k 06/04/2020
03/02/2020Aclaris Therapeutics, Inc.ACRSGrantRestricted stock units8.9k$0.00$0 03/02/2020
03/02/2020Aclaris Therapeutics, Inc.ACRSExerciseRestricted stock units8.9k$0.00$0 03/02/2020
12/17/2019Spark Therapeutics, Inc.ONCEOtherCommon Stock40.2k$114.50$4.6M 12/17/2019
12/17/2019Spark Therapeutics, Inc.ONCEOtherCommon Stock481.3k$114.50$55.1MSee Footnote12/17/2019
12/17/2019Spark Therapeutics, Inc.ONCEDispositionStock Option (Right to Buy)4k$81.53$326.1k 12/17/2019
12/17/2019Spark Therapeutics, Inc.ONCEDispositionStock Option (Right to Buy)4k$50.93$203.7k 12/17/2019
12/17/2019Spark Therapeutics, Inc.ONCEDispositionStock Option (Right to Buy)6k$56.22$337.3k 12/17/2019
06/06/2019Aclaris Therapeutics, Inc.ACRSGrantRestricted Stock Units7.3k$0.00$0 06/06/2019
05/30/2019Spark Therapeutics, Inc.ONCEExerciseRestricted Stock Units1.5k$0.00$0 05/30/2019
01/04/2019Spark Therapeutics, Inc.ONCEExerciseStock Option (right to buy)37.2k$3.45$128.4k 01/04/2019
10/22/2018Aclaris Therapeutics, Inc.ACRSPurchaseCommon Stock372.1k$10.75$4MSee Footnote10/22/2018
06/07/2018Aclaris Therapeutics, Inc.ACRSGrantStock Option (right to buy)8k$18.35$146.8k 06/07/2018
05/31/2018Spark Therapeutics, Inc.ONCEExerciseRestricted Stock Units1.5k$0.00$0 05/30/2018
05/30/2018Spark Therapeutics, Inc.ONCEGrantStock Option (right to buy)4k$81.53$326.1k 05/30/2018
05/30/2018Spark Therapeutics, Inc.ONCEGrantRestricted Stock Units1.5k$0.00$0 05/30/2018
07/24/2017Spark Therapeutics, Inc.ONCESaleCommon Stock199.3k$70.04$14MSee footnote07/24/2017
07/24/2017Spark Therapeutics, Inc.ONCESaleCommon Stock7.4k$71.59$526.2kSee footnote07/24/2017
07/24/2017Spark Therapeutics, Inc.ONCESaleCommon Stock4.7k$72.28$338.2kSee footnote07/24/2017
07/24/2017Spark Therapeutics, Inc.ONCESaleCommon Stock518$73.10$37.9kSee footnote07/24/2017
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy